Liver and the contraceptive pill.

Area of Science:

• Hepatology
• Endocrinology
• Oncology

Background:

• Oral contraceptives (OCs) have been widely used for decades.
• Several adverse effects associated with OCs are known, including jaundice and thromboembolic events.
• Tumor-like liver lesions have been reported in women using OCs.

Purpose of the Study:

• To review the presentation, management, and pathological features of liver tumors associated with oral contraceptive use.
• To discuss the biochemical effects of oral contraceptives on the liver, focusing on jaundice.

Main Methods:

• Literature review of reported cases and studies on oral contraceptive-associated liver lesions.
• Analysis of pathological features and clinical presentations.
• Discussion of biochemical mechanisms related to liver function and jaundice.

Main Results:

• Oral contraceptives are associated with various liver lesions, including benign tumors.
• Jaundice and other hepatic dysfunctions can occur due to biochemical alterations induced by OCs.
• Early recognition and appropriate management are crucial for patients with these liver conditions.

Conclusions:

• Oral contraceptives can lead to significant hepatic adverse effects, including tumor formation and jaundice.
• Understanding the biochemical impact of OCs on the liver is essential for clinical practice.
• Further research may elucidate precise mechanisms and improve patient outcomes.